USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: OPTIVIA BIOTECHNOLOGY, INC.
City: MENLO PARK
State: CA
Zip+4: 94025-3712
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $996,315.00 3
SBIR Phase II $3,649,397.00 2

Award List:

Development of A Comprehensive Cell-Based Transporter Assay Platform

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Dallas Bednarczyk
Award Amount: $406,969.00
Abstract:
DESCRIPTION (provided by applicant): Transporters are a class of more than 300 membrane proteins that regulate how nutrients and drugs enter and leave biological cells. Transporters have validated clinical significance and affect every aspect of drug ADMET (Absorption, Distribution, Metabolism,… More

A Transporter-Based Predictive ADME Platform

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Dallas Bednarczyk
Award Amount: $439,346.00
Abstract:
DESCRIPTION (provided by applicant): Desirable drug ADME (Absorption, Disposition, Metabolism and Elimination) properties are key determinants of a drug's to safety and efficacy. Unfortunately, poor ADME and Toxicity attributes have caused more drug failur es than any other factors. There is a… More

A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Yong Huang – 650-324-3177
Award Amount: $1,847,303.00
Abstract:
DESCRIPTION (provided by applicant): Transporters are a class of more than 1000 membrane proteins that regulate how nutrients and drugs enter and leave biological cells. Transporters have validated clinical significance and affect every aspect of drug ADME(Absorption, Distribution, Metabolism,… More

Establishing a comprehensive inhibitory profile of marketed drugs against CNS tra

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Juan J. Fung – 650-725-7754
Award Amount: $150,000.00
Abstract:
DESCRIPTION (provided by applicant): CNS Transporters have crucial roles on neurophysiology and etiology. Inhibition of these critical transporters can have therapeutic benefits or cause serious side effects in the CNS. Development of an assay platform anda comprehensive profile of drugs'… More

A Comprehensive Platform to study drug interaction with physiologically important

Award Year / Program / Phase: 2013 / SBIR / Phase II
Agency: HHS
Principal Investigator: Yong Huang – 650-324-3177
Award Amount: $1,802,094.00
Abstract:
CNS Transporters have crucial roles on neurophysiology and etiology. Inhibition of these critical transporters can have therapeutic benefits or cause serious side effects in the CNS. Development of an assay platform and a comprehensive profile of drugs' inhibitory effects on important CNS… More